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Novel Technique of Craniospinal Axis Proton Therapy 
with the Spot-Scanning System 
Avoidance of Patching Multiple Fields and Optimized Ventral Dose Distribution
Beate Timmermann1, Antony Jonathan Lomax1, Luisa Nobile2, Michael Andreas Grotzer3, 
Markus Weiss3, Rolf-Dieter Kortmann4, Alessandra Bolsi1, Gudrun Goitein1 
Background and Purpose: Conventional craniospinal irradiation (CSI) is a complex procedure carrying a high risk of adverse side 
effects. Still, it is indispensable for cure in a number of pediatric brain tumors. In this study, the feasibility and the potential 
advantage of spot-scanning proton therapy for CSI are investigated. 
Material and Methods: A boy (5.5 years of age) with a recurrent medulloblastoma received CSI with a single posterior field using 
the spot-scanning system at Paul Scherrer Institute. Dose distribution to the targets and the organs at risk, treatment time, re-
producibility of patient positioning, toxicity (according to EORTC/RTOG score), and treatment outcome were evaluated. 
Results: The plan achieved a homogeneous coverage of the target volume, even using a single field. The doses to the organs 
ventral to the target were minimized. During treatment, grade 1 skin reaction and grade 2 central nervous system toxicity were 
observed. After 2 months, the boy presented with a transitory fatigue. After 24 months, he is alive and free of disease. Growth 
hormones and thyroid hormones are reduced. 
Conclusion: These results, based on a single patient, suggest that spot-scanning proton therapy for craniospinal treatment is 
feasible and safe. By applying a single dorsal field, difficulties of multiple-field patching can be avoided and the ventral dose 
spread can be minimized. 
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Innovative Technik zur Behandlung der kraniospinalen Achse mit Spot-Scanning-Protonentherapie. 
Vermeidung von Feldanschlüssen und Optimierung der ventralen Dosisverteilung 
Hintergrund und Ziel: Konventionelle Methoden der Bestrahlung der kraniospinalen Achse (CSI) sind kompliziert und beinhalten 
ein hohes Risiko für Spätfolgen. Dennoch bleibt die CSI für die Heilung einer Reihe von Hirntumoren im Kindesalter unerlässlich. 
In dieser Studie werden die Durchführbarkeit und potentielle Vorteile der Spot-Scanning-Protonentherapie geprüft. 
Material und Methodik: Ein 5,5-jähriger Junge mit Rezidiv eines Medulloblastoms sollte eine CSI erhalten und wurde am 
Paul Scherrer Institut mit einem einzigen dorsalen Feld am Spot-Scanning-System mit Protonen bestrahlt. Untersucht wurden die 
Dosisverteilung für Zielvolumina, Risikoorgane, Behandlungszeit, Reproduzierbarkeit der Lagerung, Nebenwirkungen (nach Krite-
rien der EORTC/RTOG) und Therapieergebnis. 
Ergebnisse: Mit dem Therapieplan konnte trotz der Verwendung nur eines Bestrahlungswinkels eine homogene Dosisverteilung 
für das Zielvolumen erreicht werden. Die applizierte Dosis an den ventral gelegenen Organen war vernachlässigbar. An Akuttoxi-
zitäten wurden lediglich eine Grad-1-Reaktion der Haut und eine Grad-2-Reaktion am zentralen Nervensystem beobachtet. 2 Mo-
nate nach Abschluss der Behandlung trat eine vorübergehende Abgeschlagenheit auf. Nach 24-monatiger Beobachtungszeit ist 
der Junge weiterhin tumorfrei. Wachstums- und Schilddrüsenhormone sind herabgesetzt. 
Schlussfolgerung: Die Behandlung erwies sich bei dem beschriebenen Patienten als gut durchführbar und verträglich. Mit der 
Verwendung eines einzigen dorsalen Feldes konnten Probleme durch Feldanschlüsse vermieden werden, und die Dosis ventral des 
Zielgebiets wurde minimiert. 
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Introduction 
Craniospinal irradiation (CSI) is important in the care of chil-
dren with high-risk brain tumors. However, long-term side ef-
fects are both frequent and severe [1, 7, 12, 19] depending on 
age and applied dose [11, 19, 24]. 
Technical administration of conventional CSI is difficult 
and time-consuming. Multiple fields and moving of junctions 
need to be performed routinely. Any deviation in delivering 
the prescribed dose can result in an increased rate of recur-
rences [4, 8, 14]. 
Recently, several reports on the potential benefit of pro-
tons when compared to conventional X-rays in pediatric brain 
tumors have been published [6, 13, 17, 27]. 
At the Paul Scherrer Institute (PSI), further develop-
ments have been made to administer the first CSI. 
Material and Methods 
A 5.5-year-old boy with a recurrent medulloblastoma was re-
ferred to PSI. Radiotherapy was prescribed to the neuraxis 
and the posterior fossa with total doses of 36 Gy and 54 Gy, 
respectively (4 × 2.0 CGE weekly). During radiotherapy, te-
mozolomide was administered. 
For irradiation, the child was immobilized (Figure 1) and 
computed tomography (CT) was performed for planning. 
Target volumes as well as relevant organs at risk were de-
lineated according to the guidelines of the HIT 2000 protocol 
[15]. First, 18 fractions were given to the craniospinal volume 
(Figure 2) including the vertebral bodies in order to avoid 
asymmetric growth of the spine (Figures 3a and 3b). After-
wards, the second plan encompassed the posterior fossa (Fig-
ure 4). 
Treatment was performed using the spot-scanning tech-
nique of proton therapy [21]. This method has already been 
described in detail elsewhere [18, 22, 25]. As all delivered pro-
ton pencil beams are parallel to each other, field patching is 
unnecessary. Before the delivery of each fraction, accurate pa-
tient positioning was achieved through the comparison of ana-
tomic landmarks in the planning topograms and daily orthog-
onal topograms from a dedicated CT scanner. Translation 
vector was calculated in three degrees of freedom. In case of 
rotation, the patient was repositioned. 
The absorbed doses for the gonads as well as the thyroid 
were measured by thermoluminescent dosimeters. 
Acute and long-term side effects of treatment were docu-
mented according to EORTC/RTOG criteria [3, 5]. 
Results 
The first series plan consisted of a single field delivered 
from the posterior aspect to the whole brain and spinal axis. 
Dose-volume histograms to these organs are shown in Fig-
ure 5. 
Time required for positioning procedure ranged from 7 to 
12 min. Mean daily table corrections were 0 mm (range, –2 to 
1 mm) in the lateral direction, 0 mm in the posterior-anterior 
direction (range, –1 to 1.5 mm) and –0.5 mm along the pa-
tient’s long axis (range, –3 to 2.5 mm). 
The median total time to deliver a fraction (including pa-
tient setup and imaging) was 35 min for the CSI. Median times 
on the treatment machine alone were 21 min for the CSI and 
18 min for the posterior fossa. 
Acute side effects during treatment were mild. Mild skin 
erythema and epilation (grade 1 reaction) and mild tiredness 
(Karnofsky 70–80%) were observed. Additionally, mild nau-
sea was reported and successfully treated with systemic ste-
roids (grade 2 reaction). 2 months after finishing radiother-
apy, the boy presented with fatigue and loss of appetite over 
4 weeks, which resolved spontaneously. 
Figure 2. Dose distribution with spot-scanning proton therapy for the 
craniospinal volume (sagittal CT; thin green line: planning target vol-
ume). 
Abbildung 2. Dosisverteilung mit Spot-Scanning-Protonentherapie 
für das kraniospinale Zielvolumen (sagittales CT; feine grüne Linie: Pla-
nungszielvolumen). 
Figure 1. Immobilization of the child in prone position with a vacuum 
cast and a custom-made face holder. 
Abbildung 1. Immobilisation des Kindes in Bauchlage mit Vakuum-
schale und individuell gefertigter Kopfhalterung. 
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24 months after finishing proton therapy, the boy is still 
alive and free of disease. He still presents with a mild residual 
hemiplegia. In the occipital region, a slight hair loss can still be 
observed (grade 1). Deficit of growth and thyroid hormones 
was revealed. Regarding the neuropsychological findings, 
memory is good, whereas visual, motorial and spatial skills are 
somewhat reduced. Hearing and visual tests are normal. The 
boy is attending regular school. 
Discussion 
CSI still plays a major role in the curative treatment of pediat-
ric medulloblastomas and supratentorial neuroectodermal 
brain tumors. Unfortunately, there are several well-recognized 
drawbacks such as severe late effects of treatment especially in 
very young children. Additionally, the complex technique 
which is usually performed when irradiating the entire central 
nervous system (CNS) is time-consuming, and its reliability 
and reproducibility are extremely fragile. Proton therapy is rec-
ognized as a modality carrying the potential of normal tissue 
sparing due to favorable physical characteristics. Until now, 
however, only one report on three patients treated with passive 
scattering proton therapy for the craniospinal volume has been 
published [28]. At the PSI, the use of spot scanning offers ad-
ditional advantages for the irradiation of the neuraxis. 
With this method we were able to administer a single pos-
terior field which covered the entire CNS. The application of a 
single field, together with the parallel-beam scanning ap-
proach avoids the need to patch divergent fields which always 
carries the risk for gaps or too much overlapping at the field 
junctions. It is well documented, that the risk of deviations 
from the prescribed dose in the CNS might well lead to an in-
creased risk for recurrences or to an increased risk for toxicity 
in the case of local hot spots [4, 9, 10]. 
We would like to point out, that the use of one single 
beam is unique for the CSI, as conventional photon tech-
niques, despite using modern methods, usually require three 
to four fields, and passive scattering proton therapy has also 
been reported to require up to six fields [20, 26, 28]. 
Figure 4. Dose distribution with spot-scanning proton therapy for the 
posterior fossa volume (axial CT; thin green line: planning target vol-
ume). 
Abbildung 4. Dosisverteilung mit Spot-Scanning-Protonentherapie 
für die hintere Schädelgrube (axiales CT; feine grüne Linie: Planungs-
zielvolumen). 
DVHs 
(first series plan)
0
20
40
60
80
100
120
0 10 20 30 40 50 60 70 80 90 100 110 120
Dose (%)
V
ol
um
e 
(%
) PTV1
CTV1
Heart
Thyroid
Both kidneys
Both eyes
a b
Figures 3a and 3b. Dose distribution with spot-scanning proton thera-
py for the craniospinal volume not encompassing a) the vertebral 
body and b) modified to encompass the vertebral body, respectively 
(thin green line: respective planning target volume). 
Abbildungen 3a und 3b. Dosisverteilung mit Spot-Scanning-Protonen-
therapie für das kraniospinale Zielvolumen a) ohne bzw. b) mit Ein-
schluss des Wirbelkörpers (feine grüne Linie: jeweiliges Planungsziel-
volumen). 
Figure 5. Dose-volume histograms (DVHs) to the craniospinal target 
volume and selected organs at risk. CTV: clinical target volume; PTV: 
planning target volume.
Abbildung 5. Dosis-Volumen-Histogramme (DVHs) für das kraniospi-
nale Zielvolumen und ausgewählte Risikoorgane. CTV: klinisches Ziel-
volumen; PTV: Planungszielvolumen.
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Furthermore, the posterior beam direction allowed for a 
precise individual conformation of dose to the frontal sub-
arachnoid space, which is often compromised when using con-
ventional techniques requiring face block potentially covering 
parts of the frontobase [4]. 
The sparing of organs at risk ventral to the target was in 
accordance with the findings published already by groups ex-
ploring passive scattered proton-beam therapy for the neur-
axis [23, 27] being superior as compared to electrons and 
three-dimensional conformal techniques [16]. However, inno-
vative techniques have been developed to further improve 
dose conformity. Bauman et al. reported on the potential ad-
vantage of tomotherapy for craniospinal treatment [2]. How-
ever, no clinical experiences were provided. 
Conclusion 
Spot-scanning proton therapy for the craniospinal volume has 
advantages regarding the ventral dose distribution and the in-
dividual coverage of the frontal subarachnoid space. Further-
more, the technique is less fragile for hot or cold spots as com-
pared to techniques with divergent beams, because the 
patching of multiple fields can be avoided. Therefore, the risk 
for recurrences as well as for secondary cancer is potentially 
reduced. Unfortunately, the brain constitutes the target vol-
ume of any CSI and cannot be spared. Therefore, any radio-
therapy of the complete CNS will carry the risk of brain disor-
ders and should be administered only when indispensable for 
cure. 
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